171 related articles for article (PubMed ID: 20704569)
1. Structural and mechanistic insight into how antibodies inhibit serine proteases.
Ganesan R; Eigenbrot C; Kirchhofer D
Biochem J; 2010 Sep; 430(2):179-89. PubMed ID: 20704569
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the allosteric mechanism of serine protease inhibition by an antibody.
Ganesan R; Eigenbrot C; Wu Y; Liang WC; Shia S; Lipari MT; Kirchhofer D
Structure; 2009 Dec; 17(12):1614-1624. PubMed ID: 20004165
[TBL] [Abstract][Full Text] [Related]
3. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies.
Sun J; Pons J; Craik CS
Biochemistry; 2003 Feb; 42(4):892-900. PubMed ID: 12549907
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into distinct mechanisms of protease inhibition by antibodies.
Wu Y; Eigenbrot C; Liang WC; Stawicki S; Shia S; Fan B; Ganesan R; Lipari MT; Kirchhofer D
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19784-9. PubMed ID: 18077410
[TBL] [Abstract][Full Text] [Related]
6. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
7. The many faces of protease-protein inhibitor interaction.
Otlewski J; Jelen F; Zakrzewska M; Oleksy A
EMBO J; 2005 Apr; 24(7):1303-10. PubMed ID: 15775973
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1).
Eigenbrot C; Ganesan R; Kirchhofer D
FEBS J; 2010 May; 277(10):2215-22. PubMed ID: 20402765
[TBL] [Abstract][Full Text] [Related]
9. Ecotin: a serine protease inhibitor with two distinct and interacting binding sites.
Yang SQ; Wang CI; Gillmor SA; Fletterick RJ; Craik CS
J Mol Biol; 1998 Jun; 279(4):945-57. PubMed ID: 9642073
[TBL] [Abstract][Full Text] [Related]
10. Structure of a serpin-protease complex shows inhibition by deformation.
Huntington JA; Read RJ; Carrell RW
Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
[TBL] [Abstract][Full Text] [Related]
11. A general strategy to inhibit serine protease by targeting its autolysis loop.
Jiang L; Yuan C; Huang M
FASEB J; 2021 Feb; 35(2):e21259. PubMed ID: 33417271
[TBL] [Abstract][Full Text] [Related]
12. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
[TBL] [Abstract][Full Text] [Related]
13. An evolutionarily conserved binding site for serine proteinase inhibitors in large conductance calcium-activated potassium channels.
Moss GW; Marshall J; Morabito M; Howe JR; Moczydlowski E
Biochemistry; 1996 Dec; 35(50):16024-35. PubMed ID: 8973172
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
15. Recruiting Zn2+ to mediate potent, specific inhibition of serine proteases.
Katz BA; Luong C
J Mol Biol; 1999 Sep; 292(3):669-84. PubMed ID: 10497030
[TBL] [Abstract][Full Text] [Related]
16. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
Dickinson CD; Shobe J; Ruf W
J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
[TBL] [Abstract][Full Text] [Related]
17. Allosteric antibody inhibition of human hepsin protease.
Koschubs T; Dengl S; Dürr H; Kaluza K; Georges G; Hartl C; Jennewein S; Lanzendörfer M; Auer J; Stern A; Huang KS; Packman K; Gubler U; Kostrewa D; Ries S; Hansen S; Kohnert U; Cramer P; Mundigl O
Biochem J; 2012 Mar; 442(3):483-94. PubMed ID: 22132769
[TBL] [Abstract][Full Text] [Related]
18. Oxyanion-mediated inhibition of serine proteases.
Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
[TBL] [Abstract][Full Text] [Related]
19. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
Apostoluk W; Otlewski J
Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
[TBL] [Abstract][Full Text] [Related]
20. Allosteric inactivation of a trypsin-like serine protease by an antibody binding to the 37- and 70-loops.
Kromann-Hansen T; Lund IK; Liu Z; Andreasen PA; Høyer-Hansen G; Sørensen HP
Biochemistry; 2013 Oct; 52(40):7114-26. PubMed ID: 24079451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
